Previous 10 | Next 10 |
Anika Therapeutics (ANIK -17.1%) stock plummeted following its Q4 results and downgrades by Stephens and Barrington Research. Stephens analyst Chris Cooley downgraded Anika to Equal Weight from Overweight with a price target of $35, down from $50, after the company reported mixed Q4 resu...
Anika Therapeutics, Inc. (ANIK) Q4 2021 Earnings Conference Call March 08, 2022 5:30 PM ET Company Participants Mark Namaroff – Vice President, Investor Relations, ESG and Corporate Communications Cheryl Blanchard – President and Chief Executive Officer Mike Levitz – Exec...
Anika Therapeutics press release (NASDAQ:ANIK): Q4 Non-GAAP EPS of -$0.23 misses by $0.02. Revenue of $35.82M (+9.6% Y/Y) beats by $3.77M. For further details see: Anika Therapeutics Non-GAAP EPS of -$0.23 misses by $0.02, revenue of $35.82M beats by $3.77M
Fourth quarter revenue growth of 10% year-over-year despite COVID headwinds Full-year 2021 revenue up 13% driven by strong growth in Joint Preservation and Restoration BEDFORD, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global ...
ABM, ADES, ANIK, AQST, ATER, AXDX, BEST, BKEP, BMBL, CASY, CDMO, CIVI, CRCT, CTSO, DADA, EVOK, FIGS, FLL, FLNT, FTEK, GLRE, GWRE, HDSN, MDB, MNTS, OTRK, PRSO, SFIX, SNCR, SND, SUMO, WTI, YEXT For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable...
BEDFORD, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its fourth quarter and year-end 2021 financial results after the close of the...
BEDFORD, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on December 1, 2021, Anika granted non-statutory stock options covering an aggregate of 1,069 shares...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with this event. For further details see: Anika Therapeutics (ANIK) Presents At Piper Sandler Healthcare Conference
BEDFORD, Mass., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President...
Anika Therapeutics, Inc. (ANIK) Q3 2021 Earnings Conference Call November 4, 2021, 5:00 pm ET Company Participants Mark Namaroff - Executive Director, IR & Corporate Communications Cheryl Blanchard - President & CEO Mike Levitz - EVP, CFO & Treasurer Conference Call Participants Y...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the limited market release, highlighting the growing interest and commerci...
2024-07-09 17:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 13:30:02 ET Stephens analyst issues EQUAL-WEIGHT recommendation for ANIK on May 29, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight. ANIK was trading at $25.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...